Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03425721 · ClinicalTrials.gov registry record
Histological and Microbiological Evaluation of Late Occurring Nodules With Hyaluronic Acid Dermal Fillers
A clinical trial, sponsored by Allergan.
- Completed
- Registry status
- 17
- Enrollment target
NCT03425721 is a clinical trial that has completed, run by Allergan. The registered enrollment target is 17 participants.
The verdict
NCT03425721 has completed, sponsored by Allergan.
- COMPLETED
- Registry status
- 17 participants
- Enrollment target
Study Summary
This study will determine if HA dermal filler late occurring (\> 4 weeks and \<2 years) nodules are associated with bacterial contamination (independent of filler type) and to characterize the histological response.
Interventions
- OTHER No Intervention
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 17 participants |
| Start Date | 2017-11-21 |
| Est. Completion | 2021-04-13 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03425721
The ClinicalTrials.gov registry entry for NCT03425721 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 17 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Allergan, which has 314 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which No Intervention is the first listed.
NCT03425721 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03425721 about?
NCT03425721 is a clinical study titled "Histological and Microbiological Evaluation of Late Occurring Nodules With Hyaluronic Acid Dermal Fillers". This study will determine if HA dermal filler late occurring (\> 4 weeks and \<2 years) nodules are associated with bacterial contamination (independent of filler type) and to characterize the histological response.
What is the current status of trial NCT03425721?
This trial is currently completed. The enrollment target is 17 participants. The study started on 2017-11-21. Estimated completion is 2021-04-13.
What interventions are being tested in trial NCT03425721?
The interventions under investigation include: No Intervention (OTHER).
Who is sponsoring clinical trial NCT03425721?
This trial is sponsored by Allergan, which has 314 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.